Uluslararası HastaDuyurularİletişim
HACETTEPE ÜNİVERSİTESİHASTANELERİ
Randevu Al
TR
  1. Ana Sayfa
  2. Doktorlar
  3. Prof. Dr. Gökhan Metan
GM

Prof. Dr.

Gökhan Metan

İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji · Erişkin Hastanesi

Randevu Al

Yayınlar

Kaynak: Hacettepe Üniversitesi Akademik Veri Yönetim Sistemi (AVESİS) · Tüm yayınlar (178) ↗

Makaleler 152

  1. Determinants of levofloxacin prophylaxis failure in high-risk haematology patients: a prospective study integrating resistant colonization and pharmacokinetic/pharmacodynamic target attainment—authors’ responseBOŞNAK C., METAN G., Zarakolu P., ALADAĞ KARAKULAK E., PINAR A., GÖKER H., et al.Journal of Antimicrobial Chemotherapy, cilt.81, sa.11, 2026 (SCI-Expanded, Scopus)
  2. Comparative nephrotoxicity of polymyxin B versus colistin: evidence from ensemble learning and propensity score matching-right-to-replyÖZDEDE M., BALLI TURHAN F. N., Geridönmez Ö., KARA E., METAN G.Journal of Antimicrobial Chemotherapy, cilt.81, sa.10, 2026 (SCI-Expanded, Scopus)
  3. Pharmacist-led penicillin allergy interventions and delabeling outcomes: a scoping reviewMandacı C., KARA E., METAN G.Antimicrobial Stewardship and Healthcare Epidemiology, cilt.6, 2026 (ESCI, Scopus)
  4. Eleven-Year Trends in Antimicrobial Resistance and Isolation Rates per 1000 Patient-Days of Key Gram-Positive and Gram-Negative Bacteria in a Tertiary Care Hospital in Türkiye (2014–2024)Demirtaş R. B., METAN G., Dizman G. T., HAZIROLAN G., AKOVA M., UZUN Ö.Infectious Diseases and Clinical Microbiology, cilt.8, sa.5, ss.446-460, 2026 (ESCI, Scopus, TRDizin)
  5. Determinants of levofloxacin prophylaxis failure in high-risk haematology patients: a prospective study integrating resistant colonization and pharmacokinetic/pharmacodynamic target attainmentBOŞNAK C., METAN G., Zarakolu P., Karakulak E. A., PINAR A., GÖKER H., et al.Journal of Antimicrobial Chemotherapy, cilt.81, sa.9, 2026 (SCI-Expanded, Scopus)
  6. Pharmacist involvement in antifungal stewardship programs: a systematic review of clinical, utilization, and economic outcomesKARA E., Sahin N., Yumrucu F. G., METAN G.International Journal of Clinical Pharmacy, cilt.48, sa.4, ss.1214-1227, 2026 (SCI-Expanded, Scopus)
  7. Does Antibiotic Choice for Prophylaxis Affect the Outcome of Wound Infections in Earthquake Victims?AKA N., IŞIK M. C., PAMUKÇU T., TELLİ DİZMAN G., BATUR A., KAYA E. K., et al.Infectious Diseases and Clinical Microbiology, cilt.8, sa.4, ss.402-412, 2026 (ESCI, Scopus, TRDizin)
  8. Comparative nephrotoxicity of polymyxin B versus colistin: evidence from ensemble learning and propensity score matchingÖZDEDE M., BALLI TURHAN F. N., Geridönmez Ö., KARA E., METAN G.Journal of Antimicrobial Chemotherapy, cilt.81, sa.6, 2026 (SCI-Expanded, Scopus)
  9. Posaconazole Therapeutic Drug Monitoring in Daily Practice: A Single-Center AnalysisBalaban U., Kara E., Pinar A., Gülmez Kıvanç D., Karakulak E. A., Akdagli S. A., et al.INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, cilt.42, ss.818-825, 2026 (SCI-Expanded, Scopus)
  10. Clinical pharmacist-led implementation of an intravenous-to-oral antimicrobial switch protocol: A prospective Quasi-experimental studyYumrucu F. G., KARA E., YUMRUKAYA L., ZENGİN H. Y., YEĞENOĞLU S., İNKAYA A. Ç., et al.Journal of Infection and Chemotherapy, cilt.32, sa.3, 2026 (SCI-Expanded, Scopus)
  11. Antifungal Management in Patients with Hematological Malignancies: From Primary Prophylaxis to Empirical and Diagnosis-Driven Treatment Hematolojik Maligniteli Hastalarda Antifungal Yönetim: Primer Profilaksi, Ampirik Tedavi ve Tanı Odaklı YaklaşımlarÖZKOCAMAN V., ALP KIRKIZLAR T., METAN G., UZUN Ö., PINAR İ. E., ÖZKALEMKAŞ F., et al.Turkish Journal of Hematology, cilt.43, sa.3, ss.250-261, 2026 (SCI-Expanded, Scopus, TRDizin)
  12. Towards precision antibiotic therapy: predictors and outcomes of meropenem target attainmentAKMAN AR E. D., KARA E., Karadoğan E., ÖZDEDE M., PINAR A., UZUN Ö., et al.European Journal of Hospital Pharmacy, 2026 (SCI-Expanded, Scopus)
  13. Safety of discontinuing contact precautions in patients with multidrug-resistant bacterial infection or colonizationIŞIK M. C., TELLİ DİZMAN G., Gül N. D., Tekin Demir İ., Aytaç Ak H., Zarakolu P., et al.Acta Microbiologica et Immunologica Hungarica, 2026 (SCI-Expanded, Scopus)
  14. The impact of an institutional sepsis guideline on selecting appropriate empirical treatment in patients with carbapenem-resistant gram-negative bacilli bacteremiaUzar H., Karadoğan E., SERTÇELİK A., Dizman G. T., HAZIROLAN G., UZUN Ö., et al.European Journal of Clinical Microbiology and Infectious Diseases, cilt.45, sa.1, ss.145-155, 2026 (SCI-Expanded, Scopus)
  15. In reply to the letter to the editor regarding 'battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistinBALLI TURHAN F. N., Ekinci P. B., Kurtaran M., KARA E., TELLİ DİZMAN G., SÖNMEZER M. Ç., et al.INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, cilt.66, sa.4, 2025 (SCI-Expanded, Scopus)
  16. Therapeutic drug monitoring in patients treated with vancomycin: a single center, prospective, observational, real-world studyDogan C. Z., KARA E., PINAR A., DEMİRKAN S. K., METAN G.EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, cilt.44, sa.9, ss.2159-2165, 2025 (SCI-Expanded, Scopus)
  17. Quantitative Immunoglobulin G and Interferon-Gamma Responses After Different Booster Strategies of CoronaVac and BNT162b2 Vaccines in TurkiyeOcakli A. I., Ozyar-Kurtcu S. A., Uzun M., KAŞIKCI ÇAVDAR M., Telli-Dizman G., METAN G., et al.INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, cilt.7, sa.2, ss.156-165, 2025 (ESCI, Scopus, TRDizin)
  18. INTRAVENOUS-TO-ORAL SWITCH IN ANTIMICROBIAL THERAPY: A SINGLE-CENTER, OBSERVATIONAL STUDYYumrucu F. G., KARA E., İNKAYA A. Ç., METAN G., UZUN Ö.INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, cilt.47, sa.2, ss.499, 2025 (SCI-Expanded, Scopus)
  19. Management of Infections Caused by Stenotrophomonas maltophilia: A Traditional ReviewGul Yumrucu F., KARA E., TELLİ DİZMAN G., İNKAYA A. Ç., DEMİRKAN S. K., METAN G.FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, cilt.30, sa.1, ss.1-10, 2025 (ESCI, TRDizin)
  20. Impact of Aspergillus PCR on the management of invasive aspergillosis: A tertiary care hospital experience during the COVID-19 pandemicIŞIK M. C., METAN G., ALP A., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S., UZUN Ö.DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, cilt.111, sa.3, 2025 (SCI-Expanded, Scopus)
  21. A scoring system to predict resistance to ceftolozane/tazobactam in respiratory isolates of Pseudomonas aeruginosaKaradogan E., SERTÇELİK A., TELLİ DİZMAN G., UZAR H., HAZIROLAN G., ÇAKIR B., et al.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, cilt.80, sa.3, ss.788-796, 2025 (SCI-Expanded, Scopus)
  22. The impact of the COVID-19 on the antifungal consumption and antifungal resistance in Candida species isolated from the blood cultures of critically ill patients in intensive care unitsKARA E., METAN G., Guelmez D., Arikan-Akdagli S.MEDICAL MYCOLOGY, cilt.63, sa.2, 2025 (SCI-Expanded, Scopus)
  23. Monitoring of the cerebrospinal fluid voriconazole level in a patient with recurrent Candida meningitis after pituitary surgeryÜçdal M. T., Kara E., Berker M., Pınar A., Gulmez D., Arikan-Akdagli S., et al.INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, cilt.64, sa.6, 2024 (SCI-Expanded, Scopus)
  24. Predictive modeling of mortality in carbapenem-resistant Acinetobacter baumannii bloodstream infections using machine learning.Özdede M., Zarakolu P., Metan G., Köseoğlu Eser Ö., Selimova C., Kızılkaya C., et al.Journal of investigative medicine : the official publication of the American Federation for Clinical Research, cilt.72, ss.684-696, 2024 (SCI-Expanded, Scopus)
  25. Effect of inflammation on voriconazole levels in patients with invasive pulmonary aspergillosisBAKIR EKİNCİ P., BAYRAKTAR ALKAN İ., ER A. G., Pinar A., İNKAYA A. Ç., DEMİRKAN S. K., et al.JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, cilt.18, sa.10, ss.1617-1624, 2024 (SCI-Expanded, Scopus)
  26. The impact of hospital-specific guidelines on carbapenem use and patient outcomes in a setting for high endemicity with multidrug-resistant gram-negative bacilliBOŞNAK C., Findik S. B., Atay M., Fakhouri W., Babazade S., Karadogan E., et al.ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, cilt.4, sa.1, 2024 (ESCI, Scopus)
  27. An Institutional Febrile Neutropenia Protocol Improved the Antibacterial Treatment and Encouraged the Development of a Computerized Clinical Decision Support SystemTAŞ Z., METAN G., TELLİ DİZMAN G., Yavuz E., DİZDAR Ö., BÜYÜKAŞIK Y., et al.ANTIBIOTICS-BASEL, cilt.13, sa.9, 2024 (SCI-Expanded, Scopus)
  28. Optimization of appropriate antimicrobial prophylaxis in general surgery: a prospective cohort study.Doğan C. Z., Yalçın N., Cennet Ö., Metan G., Demirkan K., Yorgancı K.European journal of medical research, cilt.29, sa.1, ss.340, 2024 (SCI-Expanded, Scopus)
  29. The Impact of Reporting the Same-Day Identification and Antibiotic Susceptibility Test Results on the Treatment of Bloodstream InfectionsDEMİR M., TELLİ DİZMAN G., HAZIROLAN G., UZUN Ö., METAN G.INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, cilt.6, sa.2, ss.123-132, 2024 (ESCI, Scopus, TRDizin)
  30. Battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistin.BALLI TURHAN F. N., Ekinci P. B., Kurtaran M., KARA E., Dizman G., SÖNMEZER M. Ç., et al.International journal of antimicrobial agents, cilt.63, sa.2, ss.107035, 2024 (SCI-Expanded, Scopus)
  31. Impact of a hospital sepsis management protocol on the selection of empirical antibiotics in infectious disease consultationsÖzden A., Dalgıç B., DEMİR M., HAZIROLAN G., UZUN Ö., METAN G.Journal of Chemotherapy, cilt.36, sa.3, ss.190-197, 2024 (SCI-Expanded, Scopus)
  32. Diagnostic performance and longitudinal analysis of fungal biomarkers in COVID-19 associated pulmonary aspergillosisER B., ER A. G., GÜLMEZ KIVANÇ D., ŞAHİN T. K., METAN G., SARIBAŞ Z., et al.Heliyon, cilt.9, sa.11, 2023 (SCI-Expanded, Scopus)
  33. Does marking as sterile mean really sterile? Stenotrophomonas maltophilia outbreak caused by a blood-gas injector containing liquid heparin.Telli Dizman G., Metan G., Karahan G., Tanrıverdi E. S., Hazırolan G., Otlu B., et al.Infection control and hospital epidemiology, cilt.44, ss.1683-1685, 2023 (SCI-Expanded, Scopus)
  34. Cessation of Rectal Screening for Vancomycin-Resistant Enterococci: Experience from a Tertiary Care Hospital from Türkiye.Telli Dizman G., Metan G., Zarakolu P., Tanrıverdi E. S., Hazırolan G., Aytaç Ak H., et al.Healthcare (Basel, Switzerland), cilt.11, sa.19, 2023 (SCI-Expanded, SSCI, Scopus)
  35. Yoğun Bakım Ünitelerinde Floresan İşaretleme Yöntemi ile Temizlik Dezenfeksiyonun Değerlendirilmesi ve Çapraz Denetimin ÖnemiTelli Dizman G., Metan G., CINAR B., Tekin İ., Zengin H., Akyürek Y., et al.Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, cilt.28, sa.3, ss.466-471, 2023 (ESCI, TRDizin)
  36. Knowledge of isolation precautions among the healthcare workers in the emergency department of a university hospitalSertçelik A., Arslan V., Karadogan E., Uzar H., Cakir B., Metan G.Acta Medica, cilt.54, sa.3, ss.241-251, 2023 (TRDizin)
  37. Necrotizing pneumonia due to Aspergillus and Salmonella after immune checkpoint inhibitor treatment: An unusual case and review of the literature Neumonía necrotizante por Aspergillus y Salmonella tras tratamiento con un inhibidor de puntos de control inmunitario: un caso inusual y revisión de la literaturaIŞIK M. C., KARCIOĞLU O., HAZIROLAN G., GÜLMEZ KIVANÇ D., ONUR M. R., KUNT M. M., et al.Revista Iberoamericana de Micologia, cilt.40, sa.2-3, ss.26-30, 2023 (SCI-Expanded, Scopus)
  38. Evaluation of risk factors for developing COVID-19 in healthcare professionals working at two university hospitals in Turkey.Sertçelik A., Cakir B., Metan G.Work (Reading, Mass.), cilt.74, sa.3, ss.799-809, 2023 (SSCI, Scopus)
  39. Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wardsGÜVEN D. C., EROĞLU İ., Ismayilov R., ULUSOYDAN E., AKTEPE O. H., TELLİ DİZMAN G., et al.JOURNAL OF ONCOLOGY PHARMACY PRACTICE, cilt.28, sa.8, ss.1807-1811, 2022 (SCI-Expanded, Scopus)
  40. The guideline compatibility of mucormycosis management: A retrospective review of 165 case reports from European quality (EQUAL) score perspectiveBolek H., METAN G.JOURNAL DE MYCOLOGIE MEDICALE, cilt.32, sa.4, 2022 (SCI-Expanded, Scopus)
  41. Impact of HLA Polymorphism on the Immune Response to Bacillus Anthracis Protective Antigen in Vaccination versus Natural InfectionAscough S., Ingram R. J., Chu K. K. Y., Moore S. J., Gallagher T., Dyson H., et al.VACCINES, cilt.10, sa.10, 2022 (SCI-Expanded, Scopus)
  42. The impact of COVID-19 pandemic on nosocomial multidrug-resistant bacterial bloodstream infections and antibiotic consumption in a tertiary care hospitalMetan G., Cuha M. D., Hazirolan G., Dizman G., Tanriverdi E. S., Otlu B., et al.GMS HYGIENE AND INFECTION CONTROL, cilt.17, 2022 (ESCI)
  43. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemicER B., ER A. G., GÜLMEZ KIVANÇ D., ŞAHİN T. K., HALAÇLI B., DURHAN G., et al.MYCOSES, cilt.65, ss.724-732, 2022 (SCI-Expanded, Scopus)
  44. Sensitivity Affected by Disease Severity and Serum Sampling Time: a Performance Evaluation of Six SARS-CoV-2 Antibody ImmunoassaysŞENER B., KIRBAŞ E., SANCAK B., Gozalan A., EVREN E., KARAHAN Z. C., et al.JAPANESE JOURNAL OF INFECTIOUS DISEASES, cilt.75, sa.4, ss.388-394, 2022 (SCI-Expanded, Scopus)
  45. Is there still a room for improvement in antimicrobial use in a setting where use of broad-spectrum antibiotics require approval of an infectious diseases physician?Metan G., UZUN Ö., Dizman G., SÖNMEZER M. Ç., İNKAYA A. Ç., HAZIROLAN G., et al.Infection control and hospital epidemiology, cilt.43, sa.6, ss.802-804, 2022 (SCI-Expanded, Scopus)
  46. Sources of Infection and Risk of COVID-19 for Healthcare Workers at a Tertiary HospitalŞahan C., Kalaycı D., Erik H. E., Öntaş E., Yıldırım Pak D., Özyürek D., et al.Erciyes Medical Journal, cilt.2022, ss.1-7, 2022 (ESCI, TRDizin)
  47. It is time to define an organizational model for the prevention and management of infections along the surgical pathway: a worldwide cross-sectional surveySartelli M., Labricciosa F. M., Coccolini F., Coimbra R., Abu-Zidan F. M., Ansaloni L., et al.WORLD JOURNAL OF EMERGENCY SURGERY, cilt.17, sa.1, 2022 (SCI-Expanded, Scopus)
  48. A COVID-19 first evaluation clinic at a university hospital in Turkey.Telli Dizman G., Metan G., Ayaz Ceylan Ç. M., Altunay H., Uzun M., Gürsoy G., et al.Turkish journal of medical sciences, cilt.52, sa.1, ss.1-10, 2022 (SCI-Expanded, Scopus, TRDizin)
  49. Do antimicrobial stewardship programs improve the quality of care in ICU patients diagnosed with infectious diseases following consultation? Experience in a tertiary care hospitalGÜRSOY G., UZUN Ö., METAN G., YILDIRIM M., BAHAP M., DEMİRKAN S. K., et al.International Journal of Infectious Diseases, cilt.115, ss.201-207, 2022 (SCI-Expanded, Scopus)
  50. Disseminated Brucella melitensis infection following canakinumab treatment.Oral H., Sönmezer M. Ç., Yıldız A. E., Hazırolan G., Metan G., İnkaya A. Ç.Travel medicine and infectious disease, cilt.45, ss.102227, 2022 (SCI-Expanded, Scopus)
  51. Voriconazole Therapeutic Drug Level Monitoring: A University Hospital ExperienceKARA E., BAKIR EKİNCİ P., METAN G., EKİNCİOĞLU A., PINAR A., AKOVA M., et al.FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, cilt.27, sa.1, ss.183-188, 2022 (ESCI, TRDizin)
  52. Back to the First Days of the Pandemic: How Well Have We Done to Diagnose COVID-19 in Healthcare Workers?SERTÇELİK A., METAN G., TELLİ DİZMAN G., Atılmış D., Şahan C., KALAYCI D., et al.FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, cilt.27, sa.4, ss.555-561, 2022 (TRDizin)
  53. Human Ace D/I Polymorphism Could Affect the Clinicobiological Course of COVID-19.Aladag E., Tas Z., Ozdemir B. S., Akbaba T. H., Akpınar M. G., Goker H., et al.Journal of the renin-angiotensin-aldosterone system : JRAAS, cilt.2021, ss.5509280, 2021 (SCI-Expanded, Scopus)
  54. Implementation of Pharmacist-Driven Antifungal Stewardship Program in a Tertiary Care HospitalKARA E., METAN G., Bayraktar-Ekincioglu A., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S., DEMİRKAZIK F., et al.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, cilt.65, sa.9, 2021 (SCI-Expanded, Scopus)
  55. First Confirmed Cases of 2019 Novel Coronavirus in a University Hospital in Turkey: Housemate InternistsUYAROĞLU O. A., ÇALIK BAŞARAN N., ÖZIŞIK L., TAŞ Z., TELLİ DİZMAN G., İNKAYA A. Ç., et al.Acta Medica, cilt.52, sa.1, ss.75-81, 2021 (TRDizin)
  56. Clinical features and outcomes of COVID-19 in patients with solid tumors: Turkish National Registry DataOzdemir N., DİZDAR Ö., YAZICI O., AKSOY S., Dede D. S., Budakoglu B., et al.INTERNATIONAL JOURNAL OF CANCER, cilt.148, sa.10, ss.2407-2415, 2021 (SCI-Expanded, Scopus)
  57. SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in TurkeyÖzdemir A., Demir Çuha M., Telli Dizman G., Alp A., Metan G., Şener B.MIKROBIYOLOJI BULTENI, cilt.55, sa.2, ss.223-232, 2021 (SCI-Expanded, Scopus, TRDizin)
  58. First confirmed cases of 2019 Novel Coronavirus in a university hospital in Turkey: housemate internistsUyaroğlu O. A., ÇALIK BAŞARAN N., ÖZIŞIK L., TAŞ Z., TELLİ DİZMAN G., İNKAYA A. Ç., et al.Acta Medica, cilt.52, sa.1, ss.75-81, 2021 (TRDizin)
  59. Might Confounding Factors Have an Effect on Suboptimal Dosing of Fluconazole in Critically Ill Patients?Kara E., Bayraktar Ekincioglu A., Metan G.Antimicrobial agents and chemotherapy, cilt.65, 2021 (SCI-Expanded, Scopus)
  60. Is COVID-19 a risk factor for invasive pulmonary aspergillosis in critically ill patients?Berrin E. R., Gorkem A. E. R., METAN G., HALAÇLI B., Ersoy E. O., HAZIROLAN G., et al.TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, cilt.69, sa.1, ss.118-120, 2021 (ESCI, Scopus, TRDizin)

AVESİS'te 152 kaydın tamamı →

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 24

  1. Kan izolatı Lactobacillus rhamnosus dikkate alınmalı mı? Hacettepe Üniversitesi Hastanesinde izole edilen, dünyada ilk kez bildirilen OXA-48 pozitif bir L. rhamnosus olgusuHAZIROLAN G., GÜNDOĞDU A., ceylan f., METAN G., ALTUN B., GÜR D., et al.Uluslararası XXXVIII Türk Mikrobiyoloji Kongresi, Starlight Hotel Convention Center, Antalya, Türkiye, 4 - 08 Kasım 2018, (Özet Bildiri)
  2. Cystoisospora belli infection in renal transplant recipient in a university hospitalÖZMEN ÇAPIN B. B., SÖNMEZER M. Ç., Tortop S., ÜNALAN E. T., Bölek H., ALTINTOP S. E., et al.Uluslararası 38. Türk Mikrobiyoloji Kongresi, 4 - 08 Kasım 2018, (Özet Bildiri)
  3. Impact of effective antibiptic therapy on mortality in patients with XDR Acinetobacter baumannii bloodstream infectionsZARAKOLU KÖŞKER I. P., AKOVA M., ESER Ö., Özdede M., METAN G.20th Symposium on Infections in the immunocompromised host, Atina, Yunanistan, 17 - 19 Haziran 2018, (Tam Metin Bildiri)
  4. Compliance to the guideline of diagnostic tests in febrile neutropenic patients at a Turkish university hospital’ZARAKOLU KÖŞKER I. P., AKOVA M., BÜYÜKAŞIK Y., DURUSU TANRIÖVER M., DİZDAR Ö., METAN G., et al.20th Symposium on Infections in the immunocompromised host, Atina, Yunanistan, 17 - 19 Haziran 2018, (Tam Metin Bildiri)
  5. Emergence of collistin and carbapenem resistant Acinobacter baumannii in neurological intensive care unitMETAN G., ZARAKOLU KÖŞKER I. P., TEKİN I., AYTAÇ h., METİN B. C., ÜNAL S.28th ECCMID, 21 - 24 Nisan 2018, ss.267, (Tam Metin Bildiri)
  6. Molecular epidemiology and virulence determinants of Escherichia coli ST131/H30 clone/ subclone among bloodstream isolatesZARAKOLU KÖŞKER I. P., İLBAY A., METAN G., ESER Ö., gürpınar ö.28th European Congress of Clinical Microbiology and Infectious Diseases, Madrid, İspanya, 21 - 24 Nisan 2018, (Tam Metin Bildiri)
  7. Emergence of colistin and carbapenem resistant Acinetobacter baumannii in neurological intensive care unitZARAKOLU KÖŞKER I. P., ÜNAL S., METAN G., bölek e., aytaç h., metin b., et al.Proc. 28th European Congress of Clinical Microbiology and Infectious Diseases, p. E0121, p. 267, Madrid, Spain, 2018., Madrid, İspanya, 21 - 24 Nisan 2018, (Tam Metin Bildiri)
  8. Correlation between ST131/H30 Clone/Subclone and Carbapenem-Resistance Genes in Fluoroquinolone Resistant and Sensitive Blood Isolates of Escherichia coliESER Ö., ZARAKOLU KÖŞKER I. P., METAN G., İLBAY A., Gürpınar Ö.27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienna, Austria, 22-26 April 2017, 22 Nisan 2017, (Özet Bildiri)
  9. Kan yolu enfeksiyonlarından izole edilen Escherichia coli lerde karbapenem direnç genleri ve ST131 H30 varlığıGürpınar Ö., İlbay A., METAN G., ZARAKOLU KÖŞKER I. P., ESER Ö.Türk Mikrobiyoloji Kongres, Antalya, Türkiye, 16 - 20 Kasım 2016, (Tam Metin Bildiri)
  10. Çok Modelli El Hijyeni Geliştirme Stratejisi İçin Uygulama Kılavuzu ile El Hijyeni Uyumunun ArttırılmasıAYTAÇ h., ÇINAR b., ZENGİN h., TEKİN i., BAŞBUĞ z., METAN G., et al.Hastane İnfeksiyonları Kongresi 2016, Antalya, Türkiye, 30 Mart - 03 Nisan 2016, cilt.20, ss.206-207, (Tam Metin Bildiri)
  11. Sitomegalovirüs Pnömonisi: Ateşli İmmünsuprese Hastada Kaçırılmaması Gereken TanıYEKEDÜZ E., ASLAN A. T., ÇALIK BAŞARAN N., ÖZIŞIK L., METAN G., APRAŞ BİLGEN Ş. Ş.17. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 14 - 18 Ekim 2015, ss.165, (Özet Bildiri)
  12. Sitomegalovirüs pnömonisi ateşli immünsuprese hastada kaçirilmamasi gereken tanıASLAN A. T., ÇALIK BAŞARAN N., ÖZIŞIK L., YEKEDÜZ E., METAN G., APRAŞ BİLGEN Ş. Ş.17. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 14 - 18 Ekim 2015, ss.165
  13. Evaluation of causes of diarrhoea in peripheral stem cell transplant recipient patientsKAYNAR L., PALA Ç., Buyukoglan R., Kurnaz F., Metan G., Yazar S., et al.39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, Kanada, 7 - 10 Nisan 2013, cilt.48, (Özet Bildiri)
  14. Is it possible to replace pre-emptive low dose valgancyclovir treatment instead of standard gancyclovir treatment?KAYNAR L., Kurnaz F., Metan G., Mumcuoglu H., GÖKAHMETOĞLU S., Sivgin S., et al.37th European Group for Bone and Marrow Transplantation/27th Meeting of the EBMT Nurses Group/10th Meeting of the EBMT Management Group, Paris, Fransa, 3 - 06 Nisan 2011, cilt.46, (Özet Bildiri)
  15. T cell epitope mapping anthrax: the detection of CD4 epitopes in lethal factorIngram R. J., Chu K., Metan G., Ascough S., DOĞANAY M., Sriskandan S., et al.Annual Congress of the British-Society-of-Immunology, Glasgow, Birleşik Krallık, 17 - 21 Kasım 2008, cilt.125, ss.144, (Özet Bildiri)
  16. Karbapenem dirençli genişletilmiş spektrumlu beta laktamaz salgılayan Escherichia coli izolatıMETAN G., GÜLMEZ KIVANÇ D., UZUN Ö., KOCAGÖZ A. S., HASÇELİK A. G.7. Febril Nötropeni Simpozyumu, Ankara, Türkiye, 23 - 26 Şubat 2006, ss.213, (Özet Bildiri)
  17. Genişlemiş spektrumlu beta laktamaz salgılayan Morganella morganii Türkiye den ilk olgu sunumu 2005 Sözlü sunumGÜLMEZ KIVANÇ D., METAN G., ESER Ö., KOCAGÖZ A. S., HASÇELİK A. G.XII. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi KLİMİK, Antalya, Türkiye, 16 - 20 Kasım 2005, ss.204-205, (Özet Bildiri)
  18. COVID-19 Pandemisi Sürecinde Aspergillus PCR Kullanımının İnvaziv Aspergilloz Tanı ve Tedavi Kararı Üzerine Etkisi: Tek Merkezli Retrospektif AraştırmaIŞIK M. C., METAN G., ALP A., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S., UZUN Ö.
  19. SURVEILLANCE FOR INVASIVE PULMONARY ASPERGILLOSIS IN CRITICALLY ILL PATIENTS WITH COVID-19ER B., ER A. G., GÜLMEZ KIVANÇ D., ŞAHİN T. K., HALAÇLI B., DURHAN G., et al.
  20. Saglık çalışanlarında COVID-19 seroprevalansı: Bir ünverste hastanesi verilerinin retrospektif analiziÖZDEMİR A., DEMİR M., TELLİ DİZMAN G., ALP A., METAN G., ŞENER B.
  21. COVID-19 YOĞUN BAKIM HASTALARINDA INVAZIV PULMONER ASPERGILLOZIS IÇIN BIR RISK FAKTÖRÜ MÜDÜR?ER B., ER A. G., METAN G., HALAÇLI B., ORTAÇ ERSOY N. E., HAZIROLAN G., et al.
  22. Is COVID-19 a risk factor for invasive pulmonary aspergillosis in critically ill patients?ER B., ER A. G., METAN G., HALAÇLI B., ORTAÇ ERSOY N. E., HAZIROLAN G., et al.
  23. The importance of awareness for malaria regarding prophylaxis and early diagnosis: two important malaria cases in TurkeyÖZMEN ÇAPIN B. B., SÖNMEZER M. Ç., TORTOP s., ÜNALAN E. T., BÖLEK h., ALTINTOP S. E., et al.
  24. The İmportance of Awareness for MAlaria Regarding Prophylaxis and Early Diagnosis: Two Imported Malaria Cases in TurkeyÖZMEN ÇAPIN B. B., SÖNMEZER M. Ç., Tortop S., ÜNALAN E. T., Bölek H., ALTINTOP S. E., et al.

Kitaplar 2

  1. DENEYİM: PANDEMİDE ÇALIŞAN SAĞLIĞI BİRİMLERİ HACETTEPE ÜNİVERSİTESİŞAHAN C., METAN G., TELLİ DİZMAN G., DURUSU TANRIÖVER M., ÇALIK BAŞARAN N.TTB COVID-19 Pandemisi 6. Ay Değerlendirme Raporu, Türk Tabipler Birliği, Editör, Türk Tabipleri Birliği COVID-19 İzleme Kurulu, Ankara, ss.330-342, 2020
  2. Health Technology Assessment Report on the Rapid Molecular Diagnostic Tests Used for Identifying the Causing Agent in the Blood Sample in SepsisÖKSÜZ M. E., MALHAN B. S., ÜNAL S., ARSLAN A. H., METAN G., KAVUNCUBAŞI Ş.Republic Of Turkey Ministry Of Health, 2019

İletişim

Bölüm
İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji, Erişkin Hastanesi

Son güncelleme: